Diabetes Bites Newsletter: February 2018

Home/Diabetes Bites Newsletter: February 2018
Diabetes Bites Newsletter: February 20182018-02-15T15:16:12+00:00

February 2018

1702, 2020

Ozemipic’s new indication, what does it mean for type 1 diabetes management?

By |February 17th, 2020|

Novonordisk announced an additional indication for their GLP-1 medications Ozempic to “reduce the risk of major adverse cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease."